Small Molecule API Manufacturing Upgrades Enhance Pharmaceutical Supply Stability
As the global supply chain landscape continues to evolve, Small Molecule APIs will continue to play a vital role in the pharmaceutical industry.
2026-02-23
Pharmaceutical Formulation Development Strengthens Drug Market Competitiveness
Pharmaceutical formulation development will place greater emphasis on differentiation and refined management. By continuously optimizing formulation structures and processes, companies can lay a more solid foundation for drug commercialization
2026-02-23
Therapeutic Peptides: An Emerging Therapeutic Force in Modern Medicine
With technological advancements, accumulated clinical experience, and the emergence of more innovative peptide drugs, therapeutic peptides are gradually moving from laboratory research to clinical application, demonstrating their irreplaceable potential in modern medicine
2026-02-12
Date：23-26 March 2026 Venue：New York, USA CDMO & Tides Meeting Hotel: InterContinental New York Barclay, Room 1146 API Meeting Hotel: The Fifty Sonesta New York– Room 1905
2026-02-11
Oligonucleotide Synthesis Supports the Rapid Development of Nucleic Acid Drugs
As the commercialization of nucleic acid drugs continues to advance, oligonucleotide synthesis technology will continue to play a key role in future biomedical innovation
2026-02-02
Peptide Synthesis Provides Stable Support for Peptide Drug Development
In the trend of continuously increasing peptide drug research and development, a mature and reliable peptide synthesis service platform is becoming an important guarantee for project success
2026-01-26
Drug Conjugates Technology Drives Continuous Upgrades in Precision Medicine
As technology platforms gradually mature, Drug Conjugates are expected to achieve broader applications in oncology, autoimmune diseases, and other complex diseases, becoming an important component of the precision medicine system
2026-01-19
How Do Small Molecule APIs Support Continuous Innovation in the Pharmaceutical Industry
With the continuous advancement of innovative drugs and high-end generic drugs, Small Molecule APIs are upgrading from traditional manufacturing to high-tech, high-value-added production
2026-01-12
Business Collaboration
Innovative Drug CDMO Services
Tel: 86-576-85588039 / 86-576-85580090
E-mail: bd@jiuzhoupharma.com
